Associate Professor of Medicine, University Wash
Hematology
Dr. Stephen H. Petersdorf, MD
|
|
Give Review
Stephen H. Petersdorf, MD works in the field of Hematology. He over the years received 1 awards: "Super Doctor". Stephen Petersdorf is a published doctor. He has 52 publications published. The most current publication "Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue."
Publications
- Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson.
- Specific Features Identify Patients with Relapsed or Refractory Mantle Cell Lymphoma Benefitting from Autologous Hematopoietic Cell Transplantation.
- A model for prediction of FLT3-ITD and NPM1 (without FLT3-ITD) positivity in patients with newly diagnosed Acute myeloid leukaemia.
- A phase III study of gemtuzumab ozogamicin during induction and post-consolidation therapy in younger patients with Acute myeloid leukemia.
- New Treatment Approaches for Older Adults with Multiple Myeloma.
- Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with Acute myeloid leukemia: a SWOG report.
- Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric/adult AML: a report from the Children's Oncology Group and SWOG.
- Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory Acute myeloid leukaemia.
- Histology and Time to Progression Predict Survival for Lymphoma Recurring after Reduced-Intensity Conditioning and Allogeneic Hematopoietic Cell Transplantation.
- A Phase I/II Study of Chemotherapy Followed by Donor Lymphocyte Infusion plus Interleukin-2 for Relapsed Acute Leukemia after Allogeneic Hematopoietic Cell Transplanta...
- Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with Acute myeloid leukemia.
- High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin Lymphoma: the Seattle experience.
- External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Onco...
- Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-Cell transplantation followed by randomization to therapy with interleukin-2 ...
- Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated a...
- High-dose 131Itositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-Cell transplantation for adults > or = 60 years old with relapsed or refr...
- Age and Acute myeloid leukemia.
- High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin Lymphoma:...
- High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell Lymphoma.
- Senior adult oncology clinical practice guidelines in oncology.
- Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory Lymphoma: a prospective multi-center phase II study ...
- Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell Lymphoma.
- The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular Lymphoma patients undergoing autologous hematopoietic st...
- Topical polyene antifungals in hematopoietic Cell transplant patients: tolerability and efficacy.
- Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML.
- Phase II study of clofarabine monotherapy in previously untreated older adults with Acute myeloid leukemia and unfavorable prognostic factors.
- Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse.
- A phase 2 study of lenalidomide monotherapy in patients with deletion 5q Acute myeloid leukemia: Southwest Oncology Group Study S0605.
- Infections in relapsed or refractory Acute myeloid leukemia patients given clofarabine+cytarabine.
- A phase I study of induction chemotherapy for older patients with newly diagnosed Acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC...
- A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell Lymphomas.
- Interleukin-2 after autologous stem Cell transplantation for hematologic malignancy: a phase I/II study.
- Follow-up of relapsed B-cell Lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.
- Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem Cell support in patients with refractory malignancies.
- Autologous stem cell transplantation for Hodgkin''s Disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen.
- Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant Disease.
- High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast Cancer.
- Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult Acute lymphoblastic leukemia: a South...
- Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian Cancer.
- Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin''s Lymphoma in adults 60 years of age and older.
- Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
- The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular Lymphoma.
- Samarium-153-EDTMP in bone metastases of hormone refractory proState carcinoma: a phase I/II trial.
- On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic Leukemia.
- High dose chemotherapy for the treatment of Malignant brain tumors.
- Samarium-153-EDTMP biodistribution and dosimetry estimation.
- The biology and clinical applications of erythropoietin and the colony-stimulating factors.
- Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
- Lymphoproliferative disorders presenting as Mediastinal neoplasms.
- Intrathoracic granulocytic sarcomas.
- Hematopoietic colony-stimulating factors.
Schools
Brown University Alpert Medical School
University of Washington
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Super Doctor
Hospital
-
University of Washington Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Paul C. Hendrie, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Vincent J. Picozzi Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary G. Bolton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl A. Blau, MD |
|
|
Dr. John C. Byon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manoj P. Menon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dick G. Hwang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel B. Salit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert P. Witherspoon, MD |
|
|
Dr. Mohamed Sorror, MD |
|
|
Dr. Aude Chapuis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brady G. Miller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hirohisa Nakamae, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. David P. Ng, MD |
|
|
Dr. David Wu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Maria G. Salvatierra |
|
|
Kristina E. Sohlbach |